AMPYRA for MS: Acorda Therapeutics announces wholesale pricing and patient assistance program

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced the wholesale acquisition cost (WAC) for AMPYRA™ (dalfampridine) Extended Release Tablets will be $1,056 per 30-day supply (60-count pill bottle), an annual cost of $12,850. AMPYRA was approved on January 22, 2010 by the U.S. Food and Drug Administration (FDA) as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. AMPYRA is expected to be available in March 2010.

“To that end, our assistance programs account for people who are unable to afford their medications but whose income or healthcare coverage often exclude them from other patient assistance programs. And regardless of income, people with private insurance can benefit from our co-pay program, wherever allowed by law.”

Acorda is launching a comprehensive set of services to ensure broad access to AMPYRA for people with MS, including patient assistance and co-pay programs that will be open as soon as AMPYRA is commercially available.

“AMPYRA is the first medication indicated to improve walking in people with MS, one of the most debilitating challenges associated with the disease. Acorda’s goal is to ensure that cost is not a barrier to any person with MS who may benefit from this important medication, regardless of their level of income or healthcare coverage,” said Ron Cohen, M.D., President and CEO of Acorda Therapeutics. “To that end, our assistance programs account for people who are unable to afford their medications but whose income or healthcare coverage often exclude them from other patient assistance programs. And regardless of income, people with private insurance can benefit from our co-pay program, wherever allowed by law.”

AMPYRA Patient Support Services

Acorda has established AMPYRA Patient Support Services, a dedicated resource for healthcare professionals and people with MS. Experienced customer care agents will be available to help healthcare professionals process prescriptions, work with insurance carriers to facilitate coverage, and direct patients to available assistance programs.

The AMPYRA patient assistance program is being managed by a third party organization with extensive experience in coordinating patient benefits. Patients who meet income and other requirements, regardless of their insurance status, may receive AMPRYA at no cost. This may include Individuals who have limited healthcare coverage.

Acorda has also put a program in place to help individuals with private insurance manage their co-payment costs, where allowed by law.

Healthcare professionals and people with MS can contact AMPYRA Patient Support Services at 888-881-1918 from 8:00 a.m. to 8:00 p.m. Eastern Time for more information about AMPYRA, and to learn more about the patient assistance and co-pay mitigation programs.

SOURCE Acorda Therapeutics

Comments

  1. jean claude jones jean claude jones Israel says:

    Hello, I live in Israel and I would like to know if I can get this medicine in my country ? Thank you, JC Jones

  2. Adam Adam Poland says:

    My wife has suffered the MS illness for 30 years. She has worsening abilities in walking last time. She took part in medical trial in the USA for secondary MS which failed last year. Could anybody tell me who can provide any aid to get this medicine in Poland ?

    • iwonishe iwonishe Poland says:

      Hello,

      I would like to ask if you get some information about how to get ampyra? I'm asking becouse my grandma also lives in Poland and we're wondering how to get that pills.





  3. amir ghaznavi amir ghaznavi United States says:

    My niece is living in Iran and suffering from MS for years. She can hardly move. Can she get Ampyra in Iran or can you help me to send it to her. If I want to send I need some type of financial help.

  4. Kimani Kimani Kenya says:

    Is this drug going to be available in Africa? Any chance of getting assistance with meeting the cost?

  5. amir ghaznavi amir ghaznavi United States says:

    My niece with MS can not walk but she is crawling, and live in Iran. Is there any way that I get AMPYRA for her? She has a really hard life and is still - young 32 years old. Any assistance appreciated.
    Best Regards, Amir

  6. nelson perez nelson perez Bolivarian Republic of Venezuela says:

    Please, I have MS for 8 years, slowly my ability to walk has been worsening, I am sure Ampyra will help me, how can I get Ampyra in Venezuela.

    Greetings

    Nelson Pèrez

  7. Marwa Badr Marwa Badr Egypt says:

    I have MS for almost 9 years, Ihave difficulty walking, I live in Egypt and would like to know how can I get Ampyra. Thanks

  8. AMRITA KPHLI AMRITA KPHLI India says:

    I have MS for almost 9 years, I have difficulty walking, I live in Kota, Rajasthan and would like to know how can I get Ampyra in India. Thanks

  9. saeed saeed Japan says:

    My niece has MS and needs Ampyra. She live in Iran. I live in Japan. How can I buy this drug for her?

  10. zdybski zdybski Poland says:

    How can a patient with MS purchase Ampyra in Poland?

  11. ahmed ahmed Egypt says:

    I have MS for almost 4 years, I have difficulty walking, I live in Egypt and would like to know how can I get Ampyra. Thanks

  12. Mohamed El Torky Mohamed El Torky Egypt says:

    MY wife is 37 and she have MS for almost 13 years, she has difficulty walking and it getting worth every day , I live in Egypt and Dr Tarek Tawfek has highly recommanded to go to Ampyra , i would like to joint to your Tpatient assistance and co-pay mitigation programs. and how i can get the Ampyar in egypt , whome i should contact  !! please i need to get that medicidan to my wife .thanks

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Novel imaging molecule reveals brain changes linked to progressive MS